An 8-year-old girl with secondary histiocytic sarcoma with BRAFV600 mutation following T-cell acute lymphoblastic leukemia demonstrating stable disease for 3 years on dabrafenib and trametinib – a case report and literature review
Abstract Background Histiocytic sarcoma as a secondary malignancy following childhood leukemia is extremely uncommon with fewer than 20 cases reported worldwide. They often pose a diagnostic challenge and prognosis is dismal. There is a lack of well-established clinical treatment protocols owing...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | en |
| Published: |
BioMed Central Ltd.
2025
|
| Subjects: | |
| Online Access: | http://ir.unimas.my/id/eprint/47723/1/BMC%20Histiocytic%20sarcoma.pdf http://ir.unimas.my/id/eprint/47723/ https://bmcpediatr.biomedcentral.com/articles/10.1186/s12887-025-05539-2 https://doi.org/10.1186/s12887-025-05539-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|